Dr. Jaime Benarroch-Gampel, MD, MS

Dr. Benarroch-Gampel practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Dr. Benarroch-Gampel's NPI, 1487892147, was assigned on February 3, 2009. Dr. Benarroch-Gampel holds Georgia license 076380.

Dr. Benarroch-Gampel's primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Dr. Benarroch-Gampel's primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. The medical group on file is Emory Clinic. Dmand AI also links Dr. Benarroch-Gampel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benarroch-Gampel practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Benarroch-Gampel's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Benarroch-Gampel is licensed in Georgia.

CMS data shows 164 Medicare services from Dr. Benarroch-Gampel across 7 procedure codes in 2024, for 178 Medicare patients. Medicare paid $7,918 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Benarroch-Gampel in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benarroch-Gampel's median patient age at 69, with 49% women.

In 2024, Dr. Benarroch-Gampel wrote 54 Medicare Part D claims for 21 patients. 85% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $281 in total drug cost. In 2022, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Benarroch-Gampel for performance year 2024, reported as part of a group. Dr. Benarroch-Gampel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Benarroch-Gampel, published from 2011 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Postoperative Complications, Endovascular Procedures and Vascular Surgical Procedures. Dr. Benarroch-Gampel has published most often in Ann Vasc Surg. Dr. Benarroch-Gampel's most frequent co-authors are Ravi Rajani, MD, Taylor Sohn Riall, MD and Yazan Duwayri, MD.

Dmand AI links Dr. Benarroch-Gampel to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 37 general payments to Dr. Benarroch-Gampel from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Inari Medical, Inc. paid the most, $1,348.